Anti-Human CD2 Recombinant Antibody

Product Information

Catalog Number	YR1030
Product Name	Anti-Human CD2 Recombinant Antibody
Molecular Name	Siplizumab
Alias	Anti-CD2 Recombinant Antibody, Research Grade Siplizumab
CAS Number	288392-69-8
Target	CD2[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Host	Rat
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, IP, FCM, FuncS, Neut, IF, ICC
Buffer	PBS, pH7.5
Background	Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price